Unicycive Therapeutics Inc Sustainability Reports
Unicycive Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing and commercializing novel therapies for kidney diseases. Its lead product candidates include oxylanthanum carbonate for hyperphosphatemia and UNI-494 for acute kidney injury.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
3 reports from 2022 to 2024